USPTO serial 79289194
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
PAULO A. DE ALMEIDA
PAULO A. DE ALMEIDA PATEL & ALMEIDA, P.C.16830 VENTURA BLVD SUITE 360ENCINO, CA 91436UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for diagnostic purposes other than for medical or veterinary purposes; chemical diagnostic reagents for scientific use; chemical preparations for industrial diagnostic use; chemical preparations for scientific diagnostic use; dna, genetic and other biological and diagnostic materials, namely, biological tissue cultures other than for medical or veterinary purposes, biological preparations for use in industry and science, all for non-medical and non-veterinary use in chips, arrays and sensors; diagnostic preparations for laboratory use, other than medical; diagnostic preparations for scientific purposes; diagnostic preparations, other than for medical or veterinary purposes; diagnostic reagents for scientific use; diagnostic reagents for scientific or research use, other than for medical laboratory use; diagnostic preparations, other than for medical use; chemical test paper for use with assays; chemicals for use in immuno-assay testing other than for medical or veterinary use; immunoassay reagents, other than for medical use; chemical diagnostic reagents for scientific use | ACTIVE | — |
| 009 | Assay readers for non-medical or non-veterinary use, namely microplate readers and diagnostic apparatus for the detection of pathogens for laboratory or research use in the nature of lateral flow readers; assaying instruments namely, test tubes, pipettes, pipette racks and pipette tips all for laboratory use; scientific instruments, namely, clinical chemistry analysers, namely, lateral flow readers, other than for medical or veterinary use, for testing and analyzing chemical substances for the presences, absence, or quantity of chemicals, biologics, and contaminants; scientific apparatus and instruments using dna, genetic and other biological and diagnostic materials, namely, chips and sensor chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; non-medical diagnostic testing instruments for use in immunoassay procedure, namely, electronic analyzers, namely, lateral flow readers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of chemical and biological markers; invitro diagnostic testing apparatus other than for medical use, namely, electronic analyzers, namely, lateral flow readers for testing and analyzing biological substances for the presence, absence, or quantity of biological markers; recorded and downloadable computer software in the field of diagnostics and in relation to diagnostic and assay products for communication and transmission of data; none of the aforesaid goods being microscopes, spectrometers or interferometers | ACTIVE | — |
| 035 | Business advisory services relating to diagnostic and assay product development; business development services in relation to diagnostic and assay products; business development of inventions in relation to diagnostic and assay products; business intermediary services relating to the commercialization of diagnostic and assay goods, specifically the matching of potential private investors with entrepreneurs needing funding; business consultation in relation to diagnostic and assay products; business consultancy services relating to manufacturing of diagnostic and assay products; manufacturer's representative services in relation to diagnostic and assay products | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 4, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 12, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 12, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 2, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 16, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 16, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 27, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 8, 2024 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Mar 8, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 16, 2024 | ALIE | ASSIGNED TO LIE | — |
| Sep 27, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 26, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 2, 2023 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| May 2, 2023 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| May 2, 2023 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| May 1, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 1, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 1, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 1, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 12, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 1, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 15, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 15, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 12, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 21, 2021 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Apr 3, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Mar 25, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 25, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 25, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 11, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 10, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 10, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 10, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 10, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 14, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 13, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 9, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |